The Aneurysmal Subarachnoid Hemorrhage Market size is estimated to reach $206.67 Million by 2025, growing at a CAGR of 3.9% during the forecast period 2020-2025. Subarachnoid haemorrhage (SAH) is a life-threatening type of stroke caused by bleeding into the space surrounding the brain. One-third of patients is set to survive with good recovery. Rise in the prevalence of diseases such as stroke and hypertension, and the surge in the elderly population is driving the growth of the Aneurysmal Subarachnoid Hemorrhage Market during the forecast period 2020-2025.
Aneurysmal Subarachnoid Hemorrhage Market Report Coverage
The report: “Aneurysmal Subarachnoid Hemorrhage Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Aneurysmal Subarachnoid Hemorrhage Market.
By Therapy Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Lumbar Puncture, Xanthochromia, Cerebral Angiography, and Transcranial Doppler Ultrasound.
By End User Type: Hospitals, Clinics and others
By Geography: North America, Asia-Pacific, Europe, and Rest of the World.
Key Takeaways
- Geographically, North America Aneurysmal Subarachnoid Hemorrhage Market accounted for the highest revenue share in 2019 owing to the availability of advance Healthcare facilities in the region.
- Factors such as increasing in approval of drugs and the presence of a large number of manufacturers are driving the demand of Aneurysmal Subarachnoid Hemorrhage Market during the forecast period 2020-2025.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Aneurysmal Subarachnoid Hemorrhage Market report.
Request Sample
Aneurysmal Subarachnoid Hemorrhage Market Segment Analysis - By Therapy Type
Based on Therapy Type, Aneurysmal Subarachnoid Hemorrhage Market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Lumbar Puncture, Xanthochromia, Cerebral Angiography, and Transcranial Doppler Ultrasound. Magnetic Resonance Imaging holds the largest share in terms of revenue in 2019. This is owing to the increasing incidence of accidents leads to head injuries and increasing cerebral aneurysm cases all over the world. computed tomography (CT) scan ageing is also set to be the fastest growing with a CAGR of 4.2% during the forecast period 2020-2025. This is owing to the enormous technical advances in clinical use and increase in imaging speed along with improvements in low contrast detectability and image quality.
Aneurysmal Subarachnoid Hemorrhage Market Segment Analysis - By End User
Based on End User, Aneurysmal Subarachnoid Hemorrhage Market is segmented into Hospitals, Clinics and Others. Hospital segment contributed the largest share to the Aneurysmal Subarachnoid Hemorrhage market in 2019. This is Owing to improving healthcare facilities in emerging economies and well-established medical settings in developed Countries. The Clinics segment is set to be the fastest-growing CAGR during the forecast period 2020-2025.This is owing to the increase in elderly population and rise in the incidence of brain clots.
Schedule a Call
Aneurysmal Subarachnoid Hemorrhage Market Segment Analysis - By Geography
Based on Geography the global Aneurysmal Subarachnoid Hemorrhage Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America had a dominant share in terms of revenue with overall share of 38.2% in 2019. This is owing to major healthcare providers available in U.S. Europe is set to be the fastest-growing CAGR during the forecast period 2020-2025. This is owing to rising health awareness for brain haemorrhage and other such diseases in European countries which are driving the growth of Europe Aneurysmal Subarachnoid Hemorrhage Market.
Aneurysmal Subarachnoid Hemorrhage Market Drivers
- Rise in prevalence of diseases in elderly
The major factors driving the global aneurysmal subarachnoid haemorrhage market are rise in prevalence of diseases such as stroke and hypertension and surge in elderly population. Hypertension is an important risk factor for cardiovascular morbidity and mortality, particularly in elderly people. It is a significant and often asymptomatic chronic disease, which requires optimal control and persistent adherence to prescribed medication to reduce the risks of cardiovascular, cerebrovascular and renal disease. The lifestyle modifications, such as increased alcohol consumption and smoking, further increase the risk for ASAH, which in turn stimulates the market growth.
Inquiry Before Buying
Aneurysmal Subarachnoid Hemorrhage Market Challenges
Anaesthetic management of patients with aneurysmal subarachnoid haemorrhage is challenging because of the emergency nature of the presentation, complex pathology, varied intracranial and systemic manifestations and need for special requirements during the course of management.
Aneurysmal Subarachnoid Hemorrhage Market Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Aneurysmal Subarachnoid Hemorrhage Market. Key companies of this market are among others. Actelion Pharmaceutical Ltd, Edge Therapeutics Inc, Arbor Pharmaceuticals, Mayfield Brain and Spine, Europa Group, GE Healthcare, Trivitron Healthcare, Siemens AG, Toshiba Medical Systems Corporation, and Koninklijke Philips NV others.
Aneurysmal Subarachnoid Hemorrhage Market Developments:
- In August 2019, GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging announced a new research collaboration to diagnose and monitor brain aneurysms on scans faster and more efficiently using artificial intelligence (AI).
For more Lifesciences and Healthcare related reports, please click here
Post a Comment